Zambrano J, Eblen S, Abt M, Rhett J, Muise Helmericks R, Yeh E. HUNK Phosphorylates Rubicon to Support Autophagy. Int J Mol Sci. 2019;20: pubmed publisher

Yamaguchi H, Du Y, Nakai K, Ding M, Chang S, Hsu J, et al. EZH2 contributes to the response to PARP inhibitors through its PARP-mediated poly-ADP ribosylation in breast cancer. Oncogene. 2018;37:208-217 pubmed publisher

Gao Y, Mutter Rottmayer E, Greenwalt A, Goldfarb D, Yan F, Yang Y, et al. A neomorphic cancer cell-specific role of MAGE-A4 in trans-lesion synthesis. Nat Commun. 2016;7:12105 pubmed publisher

Du Y, Yamaguchi H, Wei Y, Hsu J, Wang H, Hsu Y, et al. Blocking c-Met-mediated PARP1 phosphorylation enhances anti-tumor effects of PARP inhibitors. Nat Med. 2016;22:194-201 pubmed publisher

Abad S, Wieërs G, Colau D, Wildmann C, Delair E, Dhote R, et al. Absence of recognition of common melanocytic antigens by T cells isolated from the cerebrospinal fluid of a Vogt-Koyanagi-Harada patient. Mol Vis. 2014;20:956-69 pubmed

Ramakrishna S, Suresh B, Bae S, Ahn W, Lim K, Baek K. Hyaluronan binding motifs of USP17 and SDS3 exhibit anti-tumor activity. PLoS ONE. 2012;7:e37772 pubmed publisher

Li X, MacLeod R, Dunlop A, Edwards H, Advant N, Gibson L, et al. A scanning peptide array approach uncovers association sites within the JNK/beta arrestin signalling complex. FEBS Lett. 2009;583:3310-6 pubmed publisher